Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal
Reexamination Certificate
2006-05-16
2006-05-16
Priebe, Scott D. (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
Transgenic nonhuman animal
C800S007000, C800S015000, C800S016000, C800S017000, C800S018000
Reexamination Certificate
active
07045677
ABSTRACT:
A process for the production of a peptide is disclosed, the process comprising expressing in the milk of a transgenic, non-human, placental mammal a fusion protein which comprises the peptide to be expressed linked to a fusion partner protein which is lysozyme. The fusion protein may be separate from the milk and cleaved to yield the target peptide. A transgenic, non-human, placental mammal whose genome incorporates a DNA molecule comprising a coding sequence encoding lysozyme coupled to a peptide is also described.
REFERENCES:
patent: 5322775 (1994-06-01), Clark et al.
patent: 5366894 (1994-11-01), Clark et al.
patent: 5476995 (1995-12-01), Clark et al.
patent: 5610053 (1997-03-01), Chung et al.
patent: 5620923 (1997-04-01), Rechsteiner et al.
patent: 5650503 (1997-07-01), Archibald et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5861299 (1999-01-01), Archibald et al.
patent: 5993809 (1999-11-01), Weaver et al.
patent: 6211427 (2001-04-01), Cottingham et al.
patent: 0 181 634 (1986-05-01), None
patent: 0 590 530 (1994-04-01), None
patent: 0 771 874 (1997-05-01), None
patent: WO 88/00239 (1988-01-01), None
patent: WO 90/05188 (1990-05-01), None
patent: WO 92/11358 (1992-07-01), None
patent: WO 92/22644 (1992-12-01), None
patent: WO 93/25567 (1993-12-01), None
patent: WO 94/04672 (1994-03-01), None
patent: WO 95/27782 (1995-10-01), None
patent: WO 97/07668 (1997-03-01), None
patent: WO 97/07669 (1997-03-01), None
patent: WO 97/42835 (1997-11-01), None
patent: WO 00/29588 (2000-05-01), None
Akinbi et al., “Enhanced bacterial clearance in the airways of transgenic mice expressing a lysozyme/SP-B fusion protein,” Amer. J. Respiratory and Crit. Care Med. 159 (3, Suppl. S): A752, Mar. 1999.
Lee et al., “Expression of a bovine beta-casein/human lysozyme fusion gene in the mammasry gland of transgenic mice,” J. Biochem. Mol. Biol. 31 (4): 413-417, Jul. 1998.
Struck et al., “High concentrations of procalcitonin but not mature calcitonin in normal human milk,” Horm. Metab. Res. 34: 460-465, 2002.
Palmiter, R.D. et al., “Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes,”Nature300:611-615, MacMillan Journals Ltd. (1982).
Maga, E.A. and Murray, J.D., “Mammary Gland Expression of Transgenes and the Potential for Altering the Properties of Milk,”Biotechnol.13:1452-1458, Nature Publishing Company. (Dec., 1995).
Brignon, G. and Ribadeau-Dumas, B., “A new method for human milk protein separation,”Biochimie64:231-235, Masson (1982).
Clark, A.J., et al., “Rescuing Transgene Expression by Co-Integration,”Bio/Technol. 10:1450-1454, Nature Publishing Co. (1992).
Curtis, R.A., et al., “Protein-Protein and Protein-Salt Interactions in Aqueous Protein Solutions Containing Concentrated Electrolytes,”Biotechnol. Bioeng. 57:11-21, John Wiley & Sons, Inc. (Jan. 1998).
During, K. “A Tightly Regulated System for Overproduction of Bacteriophage T4 Lysozyme inEscherichia coli,” Protein. Expr. Purif. 4:412-416, Academic Press, Inc. (1993).
Eipper, B.A., et al., “The Biosynthesis of Neuropeptides: Peptide α-Amidation,”Annu. Rev. Neurosci. 15:57-85, Annual Reviews Inc. (1992).
Eipper, B.A., et al., “Peptidylglycine α-amidating monooxygenase: A multifunctional protein with catalytic, processing, and routing domains,”Protein Sci. 2:489-497, Cambridge University Press (1993).
Fischer, B., et al., “Physiological consequence of expression of soluble and active hen egg white lysozyme inEscherichia coli,” Appl. Microbiol. Biotechnol. 39:537-540, Springer-Verlag (1993).
Goldman, A.S., et al., “Immunologic factors in human milk during the first year of lactation,”J. Pediatr. 100:563-567, C.V. Mosby Co. (1982).
Han, K.-K., et al., “Current Developments in Chemical Cleavage of Proteins,”Int. J. Biochem. 15:875-884, Pergamon Press Ltd. (1983).
Houdebine, L.-M., “Production of pharmaceutical proteins from transgenic animals,”J. Biotechnol. 34:269-287, Elsevier Science B.V. (1994).
Ibrahimi, I.M., et al., “Determinants for protein translocation across mammalian endoplasmic reticulum. Membrane insertion of truncated and full-length prelysozyme molecules,”Eur. J. Biochem. 155:571-576, Springer International (1986).
Jacquot, J., et al., “Identification of Different Molecular Forms of Human Airway Lysozyme,”Anal. Biochem. 160:227-232, Academic Press, Inc. (1987).
Jespers, L., et al., “Overexpression of the phage lambda lysozyme cloned inEscherichia coli: use of a degenerative mixture of synthetic ribosome binding sites and increase of the protein stability in vivo,”Protein Eng. 4:485-492, Oxford University Press (1991).
Lee, S.H. and de Boer, H.A., “Production of biomedical proteins in the milk of transgenic dairy cows: the state of the art,”J. Control. Rel. 29:213-221, Elsevier Science B.V. (1994).
Lindahl, L., and Vogel, H.J., “Metal-Ion-Dependent Hydropohbic-Interaction Chromatography of α-Lactalbumins,”Anal. Biochem. 140:394-402, Academic Press, Inc. (1984).
Lollike, K., et al., “Purification of Lysozyme from Human Neutrophils, and Development of an ELISA for Quantification in Cells and Plasma,”Leukemia9:206-209, Stockton Press (1995).
Lönnerdal, B., et al., “A longitudinal study of the protein, nitrogen, and lactose contents of human milk from Swedish well-nourished mothers,”Am. J. Clin. Nutr.29:1127-1133, American Society of Clinical Nutrition (1976).
McCreath, G.E., et al., “Preparation and use of ion-exchange chromatographic supports based on perfluoropolymers,”J. Chrom. A.773:73-83, Elsevier Science B.V. (1997).
McKee, C., et al., “Production of biologically active salmon calcitonin in the milk of transgenic rabbits,”Nature Biotechnol. 16:647-651, Nature Publishing Co. (Jul. 1998).
Noppe, W., et al., “Simple two-step procedure for the preparation of highly active pure equine milk lysozyme,”J. Chrom. A719:327-331, Elsevier Science B.V. (1996).
Okun, M.M., et al., “Truncations of a Secretory Protein Define Minimum Lengths Required for Binding to Signal Recognition Particle and Translocation across the Endoplasmic Reticulum Membrane,”J. Biol. Chem. 265:7478-7484, American Society for Biochemistry and Molecular Biology, Inc. (1990).
Paleyanda, R.K., et al., “Transgenic pigs produce functional human factor VIII in milk,”Nature Biotechnol. 15:971-975, Nature Publishing Co. (1997).
Prasad, R.V., et al., “Amino Acid Sequence of Rat α-Lactalbumin: A Unique α-Lactalbumin,”Biochemistry21:1479-1482, American Chemical Society (1982).
Pursel, V.G., et al., “Genetic Engineering of Livestock,”Science244:1281-1288, American Association for the Advancement of Science (1989).
Pursel, V.G. and Rexroad, C.E. Jr., “Status of Research with Transgenic Farm Animals,”J. Anim. Sci. 71:10-19, American Society of Animal Science (1993).
Ray, M.V.L., et al., “Production of Recombinant Salmon Calcitonin by In Vitro Amidation of anEscherichia coliProduced Precursor Peptide,”Bio/Technol. 11:64-70, Nature Publishing Co. (1993).
Sloane, R.P., et al., “Expression and purification of a recombinant metal-binding T4 lysozyme fusion protein,”J. Biotechnol. 49:231-238, Elsevier Science B.V. (1996).
Vachier, M.C., et al., “Isolation of hen egg white lysozyme, ovotransferrin and ovalbumin, using a quaternary ammonium bound to a highly crosslinked agarose matrix,”J. Chrom. B. 664:201-210, Elsevier Science B.V. (1995).
Van Heeke, G., et al., “Gene Fusions with Human Carbonic Anhydrase II for Efficient Expression and Rapid Single-Step Recovery of Recombinant Proteins: Expression of theEscherichia coliF1-ATPase & Subunit,”Prot. Exp. Purif. 4:265-274, Academic Press, Inc. (1993).
Vasstran
Cottingham Ian Robert
McCreath Graham Edward
Pharming Intellectual Property BV
Priebe Scott D.
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Fusion proteins incorporating lysozyme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fusion proteins incorporating lysozyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion proteins incorporating lysozyme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3532158